drugset / Trial / NCT01710722

The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man

NCT01710722

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to compare three treatments to see which causes the most weight loss, fat loss, loss of stomach fat and improvement in blood tests like cholesterol.

Timeline

Start
2001-02
Primary completion
2002-02
Completion
2002-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 200 mg Oral
Subject Ephedrine Small molecule 25 mg Oral
Subject Leptin A-200 Protein / enzyme biologic 20 mg Subcutaneous

Indications